Last reviewed · How we verify
NCT06739330
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
trial testing Fibroscan in Thyroid Dysfunction in 150 participants. Currently enrolling.
1 May 2025
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 19 December 2024 |
| Primary completion | 1 May 2025 |
| Estimated completion | 1 May 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Fibroscan
Conditions studied
- Thyroid Dysfunction — all drugs for Thyroid Dysfunction →
- Metabolic Dysfunction-Associated Fatty Liver Disease — all drugs for Metabolic Dysfunction-Associated Fatty Liver Disease →
Sponsor
Tanta University
Who can join
18 and older, any sex, with Thyroid Dysfunction or Metabolic Dysfunction-Associated Fatty Liver Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the prevalence of thyroid dysfunction and its association with metabolic dysfunction-associated fatty liver disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06739330
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fibroscan
Trials testing the same drug.
- NCT06757348 — Fatty Liver and Pancreatic Steatosis · not yet recruiting
- NCT07042360 — Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation · recruiting
- NCT06634160 — Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozyg · recruiting
- NCT06477146 — Milk Thistle Clinical Trial in Pediatric NAFLD · Phase 2 · recruiting
- NCT06038253 — Relation Between NAFLD and BM DENSITY · not yet recruiting
Other recruiting trials for Thyroid Dysfunction
Currently open trials in the same condition.
- NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06739330 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 20 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06739330.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing